Aim:

The SCICONX Journal of Endocrine and Diabetic Health (JEDH) aims to advance scientific knowledge, clinical practice, and global health initiatives related to endocrinology, diabetes, and metabolic disorders. By providing an international platform for high-quality, peer-reviewed research, the journal seeks to:

• Promote multidisciplinary collaboration among clinicians, scientists, educators, and public health professionals
• Support the discovery of innovative diagnostic tools, therapeutic strategies, and preventive approaches
• Strengthen the understanding of endocrine physiology, metabolic regulation, and disease mechanisms
• Facilitate the translation of research findings into improved patient care, clinical outcomes, and public health policies
• Encourage responsible, ethical, and transparent scientific communication within the global endocrine and diabetes community

JEDH is dedicated to fostering timely dissemination of impactful research that contributes to healthier communities worldwide.

Scope:

The journal publishes a broad range of scholarly articles covering foundational science, clinical investigation, translational research, technological advancements, and population health perspectives within the fields of endocrinology and diabetes.

The scope includes, but is not limited to, the following thematic areas:

1. Endocrine Physiology and Basic Science

• Mechanisms of hormone action, secretion, and regulation
• Molecular biology and genetics of endocrine diseases
• Cellular signaling pathways involved in endocrine function
• Endocrine receptor biology and biochemical mechanisms
• Experimental models in endocrine research

2. Disorders of the Endocrine System

Thyroid Disorders

• Thyroid dysfunction, autoimmunity, nodules, and cancer
• Advances in diagnostics including imaging and biomarkers

Adrenal and Pituitary Disorders

• Adrenal insufficiency, Cushing’s syndrome, Addison’s disease
• Pituitary adenomas, hormonal dysregulation, and neuroendocrinology

Reproductive Endocrinology

• Polycystic ovary syndrome (PCOS)
• Infertility, hypogonadism, menstrual disorders, and hormonal therapies

Growth and Metabolic Disorders

• Growth hormone deficiency/excess
• Obesity, metabolic syndrome, dyslipidemia

Endocrine Oncology

• Hormone-related cancers
• Advances in diagnosis, targeted therapies, and survivorship

3. Diabetes and Glucose Metabolism

• Type 1, Type 2, and gestational diabetes
• Novel approaches to insulin therapy and glycemic management
• Diabetic complications (neuropathy, nephropathy, retinopathy, cardiovascular effects)
• Hypoglycemia, hyperglycemia, and metabolic crises
• Emerging therapies including GLP-1 analogues, SGLT2 inhibitors, and immunotherapy
• Genetic, environmental, and epigenetic factors influencing diabetes

4. Prevention, Lifestyle, and Public Health

• Nutritional science and dietary strategies
• Obesity prevention and weight management programs
• Physical activity and behavioral interventions
• Endocrine disruptors and environmental health impacts
• Epidemiology of diabetes and endocrine diseases
• Global health strategies and community-based prevention initiatives

5. Technological and Clinical Innovations

• Continuous glucose monitoring (CGM)
• Artificial intelligence, digital therapeutics, and predictive analytics
• Remote patient monitoring and tele-endocrinology
• Wearable sensors and automated insulin delivery systems
• Advances in endocrine imaging and laboratory testing
• Biomarker discovery and precision diagnostics

6. Translational and Regenerative Medicine

• Stem cell therapies for endocrine and diabetic disorders
• β-cell regeneration and replacement therapies
• Tissue engineering and biomaterials for endocrine function
• Gene editing, gene therapy, and personalized human models

7. Pharmaceutical & Therapeutic Research

• Drug discovery, pharmacodynamics, and pharmacokinetics
• Comparative effectiveness of endocrine and diabetic medications
• Safety, quality-of-life impact, and therapeutic optimization
• Innovations in hormone replacement therapies

Article Types Accepted:

JEDH accepts the following categories of manuscripts:

• Original Research
• Review Articles & Systematic Reviews
• Case Reports & Case Series
• Clinical Trials & Protocols
• Short Communications
• Mini Reviews
• Perspectives, Opinions, and Expert Commentaries
• Editorials
• Hypothesis Papers
• Letters to the Editor

Who Should Submit?

The journal welcomes submissions from:

• Endocrinologists and diabetologists
• Researchers in biochemical, molecular, and clinical sciences
• Internal medicine specialists and primary care physicians
• Nutritionists, physiologists, and metabolic health experts
• Biomedical engineers and digital health developers
• Public health professionals and epidemiologists
• Graduate students, fellows, and academic researchers

Commitment to Scientific Quality:

JEDH adheres to strict standards of ethical publishing, scientific rigor, and transparent peer review. Each manuscript is evaluated by experienced reviewers with domain expertise to ensure:

• Scientific validity
• Relevance and originality
• Methodological accuracy

Clear contribution to endocrine and diabetic health knowledge